InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（0 笔）
内部人交易记录
董事已披露买入
0
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
无可用的信号评分。
Browse the complete record of transactions filed by Rogers Michael W, 董事. Insider active across 1 company, notably Akebia Therapeutics, Inc.. In total, 6 disclosures have been recorded. History available since 2 June 2021. The latest transaction was filed on 10 June 2025 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Rogers Michael W
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报6 总计
35,700 股Common StockSEC:0001244159-26-000001:0
35,700 股0Common StockSEC:0001562180-25-004720:0
30,000 股0Common StockSEC:0001562180-24-004907:0
30,000 股0Common StockSEC:0001562180-23-004959:0
13,700 股0Common StockSEC:0001562180-22-004976:0
13,700 股0Common StockSEC:0001562180-21-004029:0
6 条申报中的 6 条
About Rogers Michael W
Michael W. Rogers is a Director at Akebia Therapeutics, Inc. As a board member, he participates in the governance of the company and in strategic decision-making. Akebia Therapeutics is a biopharmaceutical company focused on developing innovative treatments for kidney diseases. Michael W. Rogers brings valuable experience in the sector, contributing to the strategic direction of the company.
